Medication info
Trasetpen Tablet

Trasetpen Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200804956 · Notified 2008.04.30 · Insurance code 640901370

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Use the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer another dose of this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be spaced at least 6 hours apart, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term use is required due to the nature and severity of the disease, perform regular monitoring to determine whether treatment with this medicine should continue.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate acute pain
  • moderate chronic pain
  • severe acute pain
  • severe chronic pain
View approved original text

This medication is used to relieve moderate to severe acute pain and chronic pain.

How to take

Adult dose

Elderly patients Use the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer another dose of this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be spaced at least 6 hours apart, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term use is required due to the nature and severity of the disease, perform regular monitoring to determine whether treatment with this medicine should continue.

Precautions

This medication can cause liver damage if taken by individuals who regularly consume more than three alcoholic beverages a day, so consultation with a physician or pharmacist is essential. One of the ingredients, acetaminophen, can occasionally cause serious skin reactions; if a rash or hypersensitivity occurs, discontinue use immediately. The tramadol ingredient may increase the risk of seizures if taken above the recommended dosage or with certain antidepressants and narcotics, thus caution is required. Rarely, serious allergic reactions or anaphylaxis may occur during the use of this medication, so if abnormal symptoms appear, you must inform medical personnel immediately. Patients with acute or severe bronchial asthma may experience severe respiratory suppression when using this medication, so it should only be administered in a properly equipped medical facility. Caution is needed when taking this medication with alcohol or benzodiazepines, as it may cause severe sedation, respiratory suppression, or unconsciousness. Patients with elevated intracranial pressure or head injury should be careful when taking this medication, as it may increase intracranial pressure through respiratory suppression. Tramadol can cause physical and psychological dependence, so it is essential to closely monitor for dependency if taken long-term. Acetaminophen can cause severe liver damage if overdosed, so ensure that the total daily dosage does not exceed 4,000 mg, and patients with poor liver function should consult a physician before use. Patients with the genetic characteristic of being ultra-rapid metabolizers of CYP2D6 may overproduce the active metabolite, thereby increasing the risk of respiratory suppression; consultation with a physician and enhanced monitoring are necessary before use. Children under 12 years of age or adolescents under 18 years who have undergone tonsillectomy and adenoidectomy should not take this medication, and teenagers between 12 and 18 years old should avoid it if specific risk factors are present. This medication can induce sleep apnea or hypoxia, and the risk increases with higher doses, so continuous monitoring for symptom exacerbation is necessary, and dosage should be reduced or discontinued if needed. Elderly patients or those at risk of hyponatremia should be monitored for the occurrence of hyponatremia while taking this medication. This medication may interact with certain drugs, particularly MAO inhibitors, serotonin-acting drugs, CYP3A4 and CYP2D6-related medications, central nervous system depressants, and warfarin, so caution and consulting with a physician are necessary. The safety for the fetus during pregnancy is not established, so it should only be used when the benefits outweigh the risks, and it is advisable for breastfeeding women to avoid taking this medication. Caution is required when driving or operating machinery, as this medication can cause drowsiness or dizziness. In case of overdose, serious symptoms such as respiratory suppression, seizures, and liver damage can occur, requiring immediate emergency treatment and, if necessary, administration of an antidote. This medication should be stored out of reach of children, and care should be taken to prevent abuse or accidental ingestion.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, fatal anaphylactic reactions, respiratory depression, deep sedation, coma, increased liver enzymes, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, excitement, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremors, sensory abnormalities, attention disorder, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, pupil constriction, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dryness of throat, hepatitis, generalized pruritus, cold sweat, urination disorders, erectile dysfunction, weakness, chest pain, emotional abnormality, chills, chest discomfort, lethargy, withdrawal syndrome from medication, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reaction, influence on unstable emotions, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, gait disorder, increased prothrombin time, hyponatremia, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exacerbation of migraine, involuntary muscle contractions, asthma, exertional dyspnea, cough, bronchitis, urinary retention, frequent urination, abnormalities in kidney function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, loss of appetite, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, reduced red blood cells, increased white blood cell count, decreased white blood cells, increased white blood cell count, decreased platelet count, arrhythmia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, intentional overdose, belching, chest discomfort, withdrawal symptoms, panic attack, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, urticaria, bronchospasm, toxic skin necrosis, allergic reactions, paralytic ileus, cholecystitis, abnormalities in kidney function tests, increased salivation, gastrointestinal bleeding, respiratory depression, somnolence, coma, cardiac arrest, QT prolongation, liver failure, coagulation disorders, abdominal discomfort, lethargy, pallor, increased sweating, respiratory depression, seizures, palpitations, tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress. Additionally, avoid storing in excessively hot or cold places; it is best kept at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.